Uridine Triacetate
Overview
Uridine Triacetate is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL2107381).
API suppliers (2)
Suppliers of Uridine Triacetate evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
- RAYLO CHEMICALS
- PRO BIO SINT SPA
Patent & exclusivity (US)
Per the FDA Orange Book (2 approved US products), the latest listed US patent on Uridine Triacetate expires 17 Aug 2027. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- [(2R,3R,4R,5R)-3,4-diacetyloxy-5-(2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methyl acetate
- Canonical SMILES
- CC(=O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=CC(=O)NC2=O)OC(=O)C)OC(=O)C
- InChIKey
- AUFUWRKPQLGTGF-FMKGYKFTSA-N
Do you supply Uridine Triacetate? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.